BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhang Y, Wu D, Zhao B, Tian XL, Yao TC, Li F, Liu WF, Shi AP. Application of neoadjuvant chemotherapy combined with anlotinib in occult breast cancer: A case report and review of literature. World J Clin Cases 2021; 9(4): 919-926 [PMID: 33585640 DOI: 10.12998/wjcc.v9.i4.919]
URL: https://www.wjgnet.com/2307-8960/full/v9/i4/919.htm
Number Citing Articles
1
Nicolas-de-Jesus Sanchez-Casas, Leslie-Marisol Gonzalez-Hermosillo, Abril-Carolina Mendoza-Lopez, Elda-Lizeth Nava-Flores, Ernesto Roldan-Valadez. Infiltrating Metastatic Ductal Carcinoma Initially Presenting as Axillary Lymph Node Metastases Diagnosed with PET/CT and MRI: Case Report and Brief Review of Occult Breast CarcinomaCurrent Medical Imaging Formerly Current Medical Imaging Reviews 2023; 20 doi: 10.2174/1573405620666230515090511
2
Fuxiao Fang, Qing Yuan. Anlotinib inhibits the proliferation, migration and invasion, and induces apoptosis of breast cancer cells by downregulating TFAP2COncology Letters 2021; 23(2) doi: 10.3892/ol.2021.13164
3
Cem KARAALİ, Hüseyin ESİN, Emel Ebru PALA, Enver İLHAN. Okult Meme Kanserinde Neoadjuvan Kemoterapi: Bir Olgu Sunumuİzmir Tıp Fakültesi Dergisi 2023; 2(2): 105 doi: 10.57221/izmirtip.1212817